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ABSTRACT
CD40-MEDIATED SIGNALING OF INTERLEUKIN-1P SYNTHESIS AND RESCUE
FROM APOPTOSIS IN MONOCYTES: MODULATION BY IL-4 AND IL-10
by
Jonathan C. Poe
To date, the cellular mechanisms involved in the progression of diseases characterized
by chronic inflammation, such as rheumatoid arthritis (RA), remain largely unknown.
However, cell-to-cell contact interactions between CD4+ helper T (Th) cells and
monocytes have been implicated in the induction and maintenance o f pro-inflammatory
cytokine synthesis that is characteristic to the pathogenesis o f RA. One such cytokine
produced during monocyte-Th cell contact is interleukin (IL)-ip, a mediator directly
involved in the characteristic tissue destruction that occurs in the synovia o f individuals
with RA. Previous studies in our laboratories have shown that ligation o f CD40 on
monocytes with CD40 ligand (CD40L) present on activated Th cells induces monocyte
IL-ip synthesis and rescues monocytes from apoptosis. These findings suggest a role
for CD40 signaling o f monocyte activation in the exacerbation and maintenance of
chronic inflammatory responses. This dissertation represents efforts to elucidate
components of the CD40 signaling pathway critical to monocyte activation and how
CD40-mediated signaling events are modulated by the anti-inflammatory cytokines IL-4
and IL-10.
Using either monocytes isolated from human peripheral blood or a monocytic cell line
(THP-1), cellular kinases and transcription factors activated upon CD40 ligation were
examined by western blot analyses and electrophoretic mobility shift assays (EMSA),
respectively. Also, how the specific inhibition o f these proteins affects CD40-mediated
IL-ip synthesis and rescue from apoptosis was investigated by SDS-PAGE and
apoptosis assays, respectively. Finally, the ability o f IL-4 and IL-10 to downregulate
these signaling events was examined by pre-treating monocytes with these cytokines
prior to stimulation through CD40.
CD40-dependent interleukin-1 P synthesis in monocytes was abrogated by inhibitors o f
protein tyrosine kinase (PTK) activity but not by inhibitors of protein kinase C (PKC).
Also, stimulation o f monocytes through CD40 resulted in the rapid activation of
Nuclear Factor-icB (NF-kB), an event reduced by the inhibition of PTK activity. In
addition, both EL-4 and EL-10 decreased CD40-dependent EL-ip synthesis in a dosedependent manner individually and synergized in this effect when used concurrently,
with minimal effect on CD40 surface expression. Also, both IL-4 and EL-10
iii
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diminished CD40-mediated tyrosine phosphorylation of monocyte cellular proteins.
However, IL-4, but not IL-10, blocked CD40-mediated rescue from apoptosis, an event
which we have demonstrated previously to be dependent on PTK activity. The
extracellular signal-regulated kinases 1 and 2 (Erkl/Erk2) mitogen-activated protein
kinases (MAPK’s) were specifically activated upon CD40 ligation, and specific
inhibition o f Erkl/Erk2 activation diminished IL-ip production in a dose-dependent
manner. Both IL-4 and IL-10 reduced Erkl/Erk2 activation and synergized in this
effect. Finally, STAT3, a member o f the family o f transcription factors involved in
cytokine signaling, was highly phosphorylated in monocytes treated with IL-10 or with
IL-10 and EL-4 in combination but not with EL-4 alone.
Together these results suggest that in monocytes 1) CD40-mediated EL-ip synthesis and
NF-kB activation require PTK activity, 2) CD40-mediated IL-ip production is
critically dependent upon Erkl/Erk2 activity, 3) both EL-4 and EL-10 target the
Erkl/Erk2 signaling cascade in the downregulation of IL-ip synthesis, 4) IL-4 and EL
IO have divergent effects on the CD40 signaling pathway in that these cytokines are
synergistic with respect to their ability to inhibit CD40-mediated Erkl/Erk2 activation
and EL-ip synthesis, and differ in their ability to block CD40-mediated rescue from
apoptosis, and 5) STAT3 activation may be directly involved in the downregulatory
effects o f EL-10 on CD40 signaling.
The elucidation of specific components involved in CD40 signaling of monocyte
activation is important to the understanding o f how Th cell-monocyte interactions
mediate chronic inflammation, in which CD40-mediated IL-ip synthesis and enhanced
monocyte longevity may play a major role. Also, how these events can be modulated
by natural mediators such as EL-4 and IL-10 will provide insight into which signaling
proteins critical to CD40 signaling are candidates as targets for therapeutic intervention.
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CHAPTER I
INTRODUCTION

Monocvte-Derived IL-lp in the Pathogenesis o f RA
Antigen (Ag)-dependent monocyte/macrophage activation induced through
interactions with helper (CD4+) T cells (Th cells) is an important component o f cellmediated immune responses. However, monocyte activation driven by aberrant Th cell
activation is implicated in the mediation o f the characteristic tissue destruction that
occurs in rheumatoid arthritis (RA), a debilitating autoimmune disease, and high numbers
o f activated Th cells and monocytes are known to exist in the synovia o f individuals with
RA (Murphy and Reynolds 1993). Interleukin (IL)-ip production by activated monocytes
is implicated in the pathogenesis o f RA, and is thought to be involved in both the onset
and progression o f disease (Wood and others 1985; Miller and Dinarello 1987; Miossec
and others 1987). EL-ip production in RA stimulates rheumatoid synoviocytes to
produce prostaglandin Eo (PGEj), an eicosanoid that induces RA-associated pain and
edema. PGE2 in turn induces the production o f interstitial collagenase (matrix
metalloproteinase (MMP)-I) and type IV collagenase (MMP-4/gelatinase B) from these
same cells (Mizel and others 1981; Dayer and others 1986, Corcoran and others 1992).
Subsequently, interstitial collagenase and type IV collagenase, together with IL-ip,
escalate the resorption o f cartilage and bone (respectively) in affected joints (Gowen and
others 1983). Inevitable consequences o f such abnormal rates o f synovial tissue
destruction are the characteristic joint deformity and dysfunction that occur during the
1
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2
progression o f RA.

Th Cell-Mediated Mbnocvte Activation Through the CD40L-CD40 Interaction
Monocyte activation during normal immune responses involves the initial antigen
presentation event, where Th cells interact through the T cell receptor (TCR) with
monocytes in an antigen-dependent, major histocompatibility complex type II (MHC-EQrestricted fashion. Subsequent cell contact-mediated and cytokine-mediated signals result
in reciprocal activation o f both the Th cell and the monocyte. Cell contact-mediated
events involved in reciprocal Th cell-monocyte activation include interactions between
pairs o f adhesion molecules such as VLA-4:VCAM-1 and LFA-1:ICAM that facilitate
prolonged cell contact, and between pairs of costimulatory molecules such as CD28:B7
and CD40 ligand (CD40L):CD40. Signals for cellular activation derived through the
formation o f such conjugates between Th cells and monocytes are a vital component o f
cell-mediated immune responses. These interactions are also likely to occur during
chronic inflammatory responses such as in RA, resulting in the aberrant overproduction
o f pro-inflammatory cytokines such as EL-ip. In particular, recent studies strongly
implicate Th cell-dependent activation o f monocytes through the CD40L:CD40
interaction as a critical event in the onset and progression o f chronic, non-septic
inflammation. (Note: CD40L has recently been assigned its own CD designation,
CD 154, but will be referred to as CD40L throughout this dissertation).
In early studies o f the interactions between Th cells and monocytes it was
demonstrated that cell contact-mediated interactions are critical for monocyte activation
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(Stout and Suttles 1992; Stout 1993; Suttles and others 1994). Critical activation signals
could not be delivered by activated Th cell supernatants (cytokine contribution), or if cell
contact was prevented. However, key signals were generated by the incubation of
monocytes/macrophages with activated, paraformaldehyde-fixed Th cells, thus indicating
dependence upon direct cell contact (Stout and Suttles 1993). It has been demonstrated
since that time that signaling through CD40 is alone sufficient to induce substantial
inflammatory cytokine production by monocytes/macrophages (Wagner and others 1994,
Stout and others 1996).

Description. Cellular Distribution, and Functions o f CD40
CD40, a member o f the tumor necrosis factor receptor superfamily, is a
transmembrane glycoprotein of ~ 45-kDa expressed by a number of cell types
including B cells (Clark 1990), monocytes/macrophages (Alderson and others 1993;
Wagner and others 1994), dendritic cells (Caux and others 1994), thymic epithelial cells
(Galy and Spits 1992), and endothelial cells (Yellin and others 1995). CD40 signaling
has been shown to induce functional changes on these cell types that may contribute to
inflammatory responses, including cytokine production and the up-regulation of
costimulatory and adhesion molecule expression (Stout and Suttles 1996). Signaling via
CD40 is dependent upon the interaction with its natural ligand, CD40L, expressed by
activated Th cells. In B cells, CD40 signaling provides critical costimulatory signals
required for activation including proliferation and survival, isotype switching, germinal
center formation, and the generation o f memory B cells (Grabstein and others 1993;
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4
Nonoyama and others 1993; Splawski and others 1993). Crosslinking o f CD40 by antiCD40 monoclonal antibodies (mAbs) induces proliferation o f resting B cells, and
treatment o f these cells with anti-CD40 or a CD40L fusion protein, in the presence o f
cytokines including IL-4, IL-5 and EL-10 has been shown to induce antibody (Ab)
production and isotype class switching (Grabstein and others 1993; Splawski and others
1993; Banchereau and others 1994).
Circulating monocytes constitutively express CD40, and CD40 ligation has been
shown to induce monocyte-derived inflammatory cytokine production (Wagner and
others 1994), to induce nitric oxide production in macrophages (Tian and others 1995;
Stout and others 1996), and to rescue monocytes from undergoing apoptosis
(programmed cell death) induced by the deprivation of serum growth factors (Suttles
and others 1996). The role of CD40 in macrophage activation has further been
substantiated by the demonstration that activated Th cells from CD40L-knockout mice
are deficient in their ability to induce macrophage effector function (Stout and others
1996). In sum, studies thus far indicate that, at sites o f chronic inflammation, activated
T cells have the potential to activate resting monocytes in a contact-dependent, antigenindependent manner, solely through CD40 ligation. The result o f this interaction is the
production o f inflammatory cytokines and enhanced monocyte viability, leading to
maintenance (or augmentation) o f the inflammatory process. This scenario is
particularly relevant to the pathogenesis of RA. In RA, initial Th activation occurs
through autoantigen recognition, the nature o f which currently remains unknown. These
cells then home to synovial tissues (where monocytes are also present), and have the
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5
potential at this point to induce monocyte pro-inflammatory cytokine synthesis in an
antigen-independent manner, solely through CD40 ligation.
Although the nature o f the CD40 signaling pathway in monocytes has not been
elucidated, CD40 signaling in B cells has been shown to involve protein tyrosine kinase
(PTK) activity, as well as the activity o f serine/threonine kinases (Uckun and others
1991; Faris and others 1994). Signaling proteins reported to be activated through CD40
in B cells include protein kinase C (PKC), the PTK’s lyn, fyn, and syk, Ras,
phosphatidylinositol-3 (PI-3) kinase, and the c-Jun N-terminal kinase (JNK) member of
the mitogen-activated protein kinase (MAPK) family (Faris and others 1994; Ren and
others 1994; Sakata and others 1995; Gulbins and others 1996; Sutherland and others
1996). The Ras proto-oncogene product is a ubiquitously expressed GTP-binding
protein (G-protein) that is known to function in a linear cascade that leads to the
activation o f MAPK activity (Figure 1). Importantly, although CD40-mediated Ras
activation in B cells has been shown to result in the activation o f MAPK/Erk kinase 1
(MEK1) (Gulbins and others 1996), the extracellular signal-regulated protein kinases 1
and 2 (Erkl and Erk2) MAPK’s, the only known MEK1 substrates, are not subsequently
activated (Sakata and others 1995; Sutherland and others 1996). One possible
explanation for this lack o f Erk activation during CD40 signaling in B cells may be the
activity o f Erk-directed phosphatases. JNK, the only member o f the MAPK family
shown to be activated via CD40 signaling in B cells (Sakata and others 1995; Sutherland
and others 1996), is known to be activated independently o f the Ras signaling cascade
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Figure 1. The Erkl/Erk2 MAPK and JNK MAPK Signaling Cascades
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(Cobb and Goldsmith 1995). Together these observations suggest that Ras-dependent
MEK1 activation induced by CD40 ligation in B cells may be functionally insignificant,
and that JNK is the member o f the MAPK family involved in CD40-mediated B cell
activation.
In our previous work we demonstrated that the pathway o f monocyte CD40
signaling resulting in rescue from apoptosis is critically dependent on the generation o f
PTK activity and does not appear to involve activity o f the serine/threonine PKC family
(Suttles and others 1996). Beyond this, however, components involved early in CD40
signal transduction in monocytes, as well as downstream components involved in gene
transcription, are yet to be elucidated. Nuclear Factor-kappa B (NF- kB) is a ubiquitous
transcription factor involved in the transcription o f numerous genes in multiple cell types.
I kappa B (IkB) family members are responsible for inhibiting NF- kB activation by
sequestering NF-kB homodimers/heterodimers in the cytoplasm through binding o f the
NF- kB rel homology domain, resulting in the concealment of the nuclear localization
sequence (Ganchi and others 1992; Zabel and others 1993). Phosphorylation, followed
by the ubiquitination and proteasomal degradation o f IkB, allows active NF-kB to be
rapidly translocated to the nucleus where it can bind relevant gene promoters (Beg and
others 1993; Brown and others 1993; Cordle and others 1993; Henkel and others 1993;
Mellitis and others 1993). Of particular importance is the involvement o f NF-kB in the
transcription o f the genes for pro-inflammatory cytokines, including IL-lp. It has been
demonstrated that following lipopolysaccharide (LPS) stimulation, IL-ip mRNA is
rapidly transcribed (Fenton and others 1987), suggesting that preexisting transcription
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8
factors such as NF- kB are involved in transcription o f the IL-ip gene. The presence of
binding elements for NF-kB, as well as for other transcription factors including NFPA, AP-1, and NF-IL6, have been reported in the IL-lp gene promoter region (Fenton
and others 1987). In B cells, CD40 signaling has been shown to result in the activation
o f NF-kB (Lalmanach-Girard and others 1993). However, because CD40-mediated
activation o f B cells generally involves signaling events that modulate antibody
production, and not the induction o f pro-inflammatory cytokines, the nature o f NF- kB
activation as a downstream event o f CD40-mediated signaling events may be very
different in monocytes.
IL-4 and EL-10 are modulatory cytokines that have been shown to exhibit anti
inflammatory properties both in vivo and in vitro by directing Th populations toward a
Th2-like (humoral/antibody-dependent immune response) cytokine production profile
(Mosmann and Moore 1991; Sher and others 1991; Chatelain and others 1992; Maggi
and others 1992; Sher and others 1992; Mocci and Coffman 1995). Thl-like (cellmediated) responses, in contrast to Th2 responses, includes Th cell-dependent
activation of monocytes and the subsequent production o f pro-inflammatory cytokines,
including IL -ip. The primary cellular source o f IL-4 and EL-10 is the Th2 subset o f
helper T cells, although a major source o f IL-10 is also the activated
monocyte/macrophage. Direct effects o f IL-4 and IL-10 on monocyte/macrophage
function have been observed, including downregulation o f bacterial LPS-induced
macrophage inflammatory cytokine production (Hart and others 1989; de Waal Malefyt
and others 1991; Donnely and others 1990; te Velde and others 1990; Fiorentino and
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9
others 1991), and inhibition o f macrophage cytotoxic activity (Oswald and others 1992).
In addition, EL-4 has been shown to counteract the rescue o f monocytes from, serum
deprivation-induced apoptosis that is mediated through treatment with EL-1 and LPS
(Mangan and others 1992). IL-10 has been shown to induce apoptosis in monocytes
cultured in the absence of, but not in the presence of, granulocyte-macrophage colonystimulating factor (GM-CSF) and interferon-y (IFN-y) (Bach and Brashler 1995),
cytokines with potent monocyte/macrophage activating capacities.
To exert their effects, cytokines activate members o f the Janus kinase (Jak) family
o f tyrosine kinases which subsequently activate members o f a family o f transcription
factors known as “signal transducers and activators o f transcription,” or STAT’s (Figure
2). Upon cytokine receptor ligation and aggregation, one or more Jak kinases associate
with a domain known as the “boxl/box2 motif' that is located within the membraneproximal domain o f the signal-transducing chain(s) o f cytokine receptors. This
association results in the activation o f Jak kinases through Jak transphosphorylation. In
turn, activated Jak kinases phosphorylate the cytokine receptor at specific tyrosine
residues which are recognized by a src homology 2 (SH2) domain located within the
carboxy terminus o f STAT proteins. This localization o f STAT proteins to the receptor
allows for their subsequent tyrosine phosphorylation by a particular Jak kinase (Hou and
others 1994; Heim and others 1995; Stahl and others 1995). STAT phosphorylation
results in the formation o f STAT homo- or heterodimers (depending upon the STATs
activated), followed by subsequent nuclear translocation and DNA binding o f related
elements, inducing gene transcription. STAT transcription factors bind a nucleotide
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

consensus motif o f TTNCNNNAA, and slight variations that exist in this sequence
between specific genes dictates what STAT homo- heterodimers will preferentially bind
(O’Shea 1997). Although IL-4 and IL-10 have similar effects on the downregulation o f
LPS-induced monocyte activation, these cytokines utilize different Jak-STAT proteins
during signal transduction. EL-4 receptor ligation results in the activation o f STAT6 by
Jak3, while IL-10 receptor ligation results in the activation o f STAT1 and STAT3 by Jakl
and Tyk2 (Ihle 1995; O’Shea 1997).
This dissertation represents the results o f studies designed to evaluate the nature
o f kinase and transcription factor involvement in CD40 signaling o f EL-ip production
and rescue o f monocytes from apoptosis and the effects of IL-4 and EL-10 on these
CD40-mediated events. Peripheral blood monocytes or monocytic cell lines were
stimulated either with an IgM anti-CD40 mAb that mimics the interaction o f CD40 with
CD40L, or with purified plasma membranes from resting Th cells (TmP) or from 6 hactivated Th cells (TmA) (which express high levels of CD40L), in the presence or
absence o f IL-4 and/or EL-10, or inhibitors o f cellular kinase activity. The activation of
specific kinases and transcription factors that occurs upon CD40 ligation in monocytes,
and how the activation states o f these proteins (and their subsequent biologic effects)
are modulated by cell treatment with IL-4, EL-10, and kinase inhibitors, was examined
through a variety of experimental designs.
The elucidation o f components involved in CD40 signaling of monocyte IL-ip
synthesis, and how these events can be modulated by natural mediators such as IL-4
and IL-10, will provide insight into potential targets for therapeutic intervention in the
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treatment o f diseases that are characterized by chronic inflammation, such as RA.
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CHAPTER 2
MATERIALS AND METHODS

Control o f Endotoxin Contamination
All cell culture reagents used were either certified as low endotoxin when
purchased, or were ensured low endotoxin as determined by chromogenic limulus assay
(BioWhittaker, Walkersville, MD). Stock solutions containing >1 ng/ml (10 EU/ml)
were considered unacceptable. Stock solutions were diluted in assays such that endotoxin
levels did not exceed 1 pg/ml.

Inhibitors
Herbimycin A and calphostin C were purchased from Calbiochem (La Jolla, CA). H7
was purchased from Sigma Chemical Co. (St, Louis, MO). Sodium ortho vanadate
(Na3V 0 4) was aquired from Fisher Scientific, (Fair Lawn, NJ). The MEK1/MEK2
inhibitor PD98059 was obtained from New England Biolabs, Inc (Beverly, MA).

Antibodies fAbs')
Mouse IgM anti-human CD40 (BL-C4) (Monosan, the Netherlands) mAb was purchased
from Caltag Laboratories (South San Francisco, CA). The IgM isotype control Ab was
obtained from Southern Biotechnology Associates, Inc., (Birmingham, AL). The
following mAb’s were prepared from culture supernatants of hybridomas purchased
from American Type Culture Collection (ATCC, Rockville, MD): IgG mouse anti
human EL-ip (H-6A), IgG mouse anti-human CD3 (OKT-3), IgG mouse anti-human

13
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CD8 (OKT-8), IgG mouse anti-human monocyte (3C10), IgG mouse anti-human B cell
(LYM-1), IgM mouse anti-human NK cell (hNK-1), and IgG mouse anti-human CD40
(G28-5). BioMag* goat anti-human IgG and IgM was obtained from PerSeptive
Diagnostics, Inc. (Cambridge, MA). Horseradish peroxidase-conjugated antiphosphotyrosine mAb (RC20) was purchased from Transduction Laboratories
(Lexington, KY). FITC-conjugated donkey anti-mouse IgG (H + L) was purchased
from Jackson Immunoresearch Laboratories, Inc. (West Grove, PA). IgG mouse anti
human CD40L mAb was obtained from Genzyme (Cambridge, MA). Rabbit anti-active
(phospho-specific) MAPK polyclonal antibody (pAb) was aquired from Promega
(Madison, WI). Rabbit anti-active (phospho-specific) STAT pAb was purchased from
New England Biolabs, Inc.

Monocyte Isolation and Culture
For IL -lp and kinase assays, blood was collected from normal, healthy human
volunteers and PBMC's were isolated over a Ficoll density gradient (Fico-LiteLymphoH, Atlanta Biologicals, Norcross, GA). PBMC's were plated at a density o f 5
x 106 cells/well in 24-well tissue culture plates (Falcon Primaria, Lincoln Park, NJ) in
RPMI 1640 (Hyclone, Logan, UT), containing 100 mM HEPES, 50 /xg/ml gentamicin,
and 5% FBS, henceforth referred to as R-5. Monocytes were isolated by plastic
adherence for 1 h at 37 °C after which nonadherent cells were removed by Pasteur
pipetting during 2 washes with Dulbecco's PBS (DPBS). Cells were maintained in R-5
overnight prior to treatment.
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For apoptosis assays, elutriation-purified monocytes were used (cells provided
by Dr. Larry M. Wahl, National Institutes o f Health, Bethesda, MD). The THP-1
monocytic cell line was maintained in R-5 medium.

CD4H
~ T Celi Purification and Activation
CD4+ T cells were purified by negative magnetic panning from elutriationenriched T cell populations (cells provided by Dr. Larry M. Wahl, National Institutes
o f Health, Bethesda, MD). Cells were incubated in R-5 with rnAb’s against cell
surface molecules generated from the hybridomas OKT-8 (anti-CD8+ T cell), 3C10
(anti-monocyte), LYM-1 (anti-B cell), and hNK-1 (anti-NK cell), used as culture
supernatants at dilutions o f 1:10, for 30 min at RT. Cells were then treated with
BioMag* iron-conjugated antibodies to murine IgG and IgM (PerSeptives Diagnostics,
Cambridge, MA) for 30 min with gentle shaking at 4 °C. Cells were diluted with
DPBS in 75 cm2 flasks (Fisher Scientific) and the CD4" cells were removed via 27
megagauss Oerstead magnets (PerSeptives Diagnostics). A sample of the purified
population was stained with an FITC conjugated anti-CD4 mAb and analyzed by flow
cytometry on a FACS* 420 flow cytometer (Becton Dickinson, San Jose, CA). The
resulting population was typically found to be greater than 95% CD4+. CD4+ T cells
were then rested in R-5 alone, or activated for 6 h in R-5 either by plating on anti-CD3
(OKT-3)-coated tissue culture plates, or by incubation with 10 ng/ml PMA (Sigma) -+0.5 jiiM ionomycin (Calbiochem, San Diego, CA). Expression of CD40L on activated,
but not resting, CD 4+ T cells was then confirmed by flow cytometric analysis on a
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FACS® 420 flow cytometer.

T-Cell Plasma Membrane Preparation
Plasma membranes were prepared using a modification o f the method o f Noelle
and others (1991). Briefly, resting and activated elutriation-purified T cells were
resuspended in a hypotonic buffer containing 50 mM Tris-HCL, pH 7.4, 25 mM KCI, 5
mM MgCl2, and 50 fig/ml PMSF for 30 min on ice. The cells were then Douncehomogenized until completely disrupted as determined microscopically. Disrupted cells
were centrifuged at 500 x g for 5 min to remove nuclei, then centrifuged at 95,000 x g for
30 min using a Ti-50 rotor in a Beckman L5-65 Ultracentrifuge. Cell debris was
resuspended in 35% (wt/vol) sucrose/hypotonic buffer then layered on 73% (wt/vol)
sucrose/hypotonic buffer. Hypotonic buffer was layered on the 35% sucrose and the
samples were centrifuged using a SW50.1 rotor at 130,000 x g for 1 h to separate plasma
membranes. The plasma membrane layer (at the 73%-35% interface) was collected and
diluted 1:5 with hypotonic buffer, then centrifuged again for lh at 130,000 x g to pellet
purified plasma membranes. The membrane pellets were resuspended in PBS and total
protein was determined by microtiter plate protocol o f the bicinchoninic acid protein
assay (Pierce, Rockford, IL). The BCA protein assay was read on a Biotek Instruments
microtiter plate reader at 561nm.

Metabolic Protein Labeling, rmmunoprecipitation o f IL-lp. and SDS-PAGE
IL-ip induction in monocytes by anti-CD40 was measured by metabolicaliy
labeling the cells with 50 pCi/ml TranssS-Label™ (ICN Radiochemicals, Irvine, CA) in
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methionine-deficient RPMI 1640 (Hyclone, Logan, UT) supplemented with 5 jig/ml each
insulin and transferrin (Sigma). After labeling, the culture medium was removed, cells
were rinsed with DPBS and lysed in cold immunoprecipitation buffer containing 25 mM
Tris-HCL pH 7.4, 1% Triton X-100, 1% deoxycholate, 0.35 MNaCl, 10 mM EDTA, and
50 pg/ml PMSF. Lysates were immediately snap-frozen in a dry ice/ethanol bath.
Lysates were immunoprecipitated for IL-ip with mouse anti-human IL-ip followed by
isolation with Immobilized rProtein-A™ (Repligen Corporation, Cambridge, MA).
Precipitates were electrophoresed by SDS-PAGE on 15% minigels. The gels were
prepared by methanol/glacial acetic acid fixation followed by gentle shaking in
Autofluor™ (National Diagnostics, Atlanta, GA) for 45 min. Gels were then dried and
exposed to Kodak X-Omat LS X-ray film (Eastman Kodak, Rochester, NY).

Electrophoretic Mobility Shift Assay HEMSA')
THP-1 ceils cultured in R-5 were transferred to 6-well tissue culture plates at a
concentration o f 2.5x107 cells/well. After treatment or stimulation as required by the
particular assay, cells were collected and lysed to isolate nuclei based on the method o f
Buras and others (1994). Briefly, cells were lysed in hypotonic buffer containing 10 mM
KC1, 0.3 M sucrose, 10 mM P-glycerol phosphate, 0.2 mM EDTA, 0.4% nonidet P-40, 1
mM PMSF and 1 pg/ml each of leupeptin and pepstatin, on ice for 30min with
intermittent gentle agitation. Following lysis, nuclei were collected by centrifugation at
11,500 x g for 5min. Nuclear proteins were extracted by incubating nuclei in a buffer
containing 25% glycerol, 0.3 M KC1, 1.5 mM MgCL 0.2 mM EDTA, 0.5 mM
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dithiothreitol, 1 mM PMSF, and 1 pg/ml each o f leupeptin and pepstatin for 30 min on
ice. Extracts were centrifuged at 11,500 x g and supernatants were collected as nuclear
extracts. Extracts were concentrated and reconstituted to 0.1 M KC1 using Microcon
microconcentrators from Amicon (Beverly, MA). Protein determinations were performed
by the BCA micro protein assay. Extracts were aliquoted and stored at -80° C.
Binding assays were performed using a consensus oligonucleotide containing the
binding element for NF-kB (Promega Corp., Madison, WI) that was end-labeled using
j2P-gamma ATP (ICN Biomedicals Inc., Irvine, CA). Nuclear extracts were incubated
with gel shift binding buffer (4% glycerol, 1 mM MgCl2 0.5 mM EDTA, 0.5 mM DTT,
50 mM NaCl, 10 mM Tris, pH 7.5, 0.05 mg/ml salmon sperm DNA), and 32P- endlabeled oligonucleotide at approximately 5x105 cpm. Binding reactions were done at
room temperature for 20 min. Cold competition assays were performed by first adding a
40-fold concentration o f unlabeled NF-kB consensus oligonucleotide, incubating for 20
min, then adding 32P-labeled oligonucleotide. Following binding reactions, samples were
analyzed on 4% polyacrylamide gels. Following electrophoresis, gels were dried onto
Whatman filter paper and exposed to X-ray film from several hours to overnight at room
temperature. Band densities were determined with a BIO Image® Whole Band Analyzer
program (Millipore, Ann Arbor, MI) following autoradiograph scanning on a Scanmaster
3+™ scanner (Howtek, Hudson, NH).

Western Blot Analysis
Prior to stimulation, monocytes were pretreated with 50pM Na3V 0 4 for 20 min to
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negate PTP effects on tyrosine-phosphorylated cellular proteins during stimulation. After
monocyte treatment/stimulation in 24-well plates, cells were lysed in 50 pi boiling
treatment buffer (125 mM Tris, pH 6.8,2% SDS, 20% glycerol, 1% betamercaptoethanol, and 0.003% bromophenol blue) containing 1 mM each PMSF and
sodium orthovanadate. Samples were boiled an additional 5 min prior to protein
separation by SDS-PAGE on 15% minigels. Gels were equilibrated in transfer buffer (48
mM Tris, pH 9.2, 39 mM glycine, 1.3 mM SDS, and 20% methanol) for 15 min prior to
transfer. Protein transfer to nitrocellulose membranes (Coming Costar Corp.,
Kennebunk, ME) was performed at 15V for 30 min using a Trans-Blot® SD Semi-Dry
Electrophoretic Transfer Cell (Bio-Rad, Richmond, CA). Dried membranes were blocked
by gentle agitation in PBS containing 0.1% Tween 20 and 1% BSA (blocking buffer) for
30 min at 37° C. Membranes were incubated with the relevant primary Ab in blocking
buffer for 30 min at 37° C, and then washed for 10 min x2 washes in PBS containing
0.1% Tween 20 (wash buffer), followed by incubation with the relevant (HRPconjugated) secondary Ab for 30 min at 3 7 °C (if the primary antibody was not HRPconjugated), and then washed for 10 min x3 in wash buffer. Ab-bound proteins were
detected using an ECL™ Western blotting analysis system (Amersham Corp., Arlington
Heights, IL) and the membranes were exposed to Kodak X-Omat LS X-ray film (Eastman
Kodak, Rochester, NY).

Analysis o f CD40 Surface Expression
Monocytes were harvested from tissue culture plates by brisk pipetting in cold
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monocyte wash buffer (0.2% EDTA and 0.1% sodium azide in PBS). Monocytes were
stained with a 1:10 dilution o f G28-5 (IgG anti-human CD40) for 30 min at room
temperature, washed in DPBS, and stained with a FITC-conjugated donkey anti-mouse
IgG (H + L) secondary Ab for 30 min at RT. Cells were washed in DPBS and analyzed
for CD40 surface expression on a FACS® 420 flow cytometer (Becton Dickinson, San
Jose, CA).

Analysis o f Monocvte Apoptosis
Apoptosis was monitored by both agarose gel electrophoresis and flow cytometry.
Elutriation-purified monocytes were incubated with or without stimulus at 2.5 x 106 per
tube (polypropylene) in 500 pi serum free medium (R PM I1640, containing 100 mM
HEPES and 50 pg/ml gentamicin, henceforth referred to as R-0). The cells were
harvested after a 72 h incubation period. For gel electrophoresis the cells were pelleted
and lysed in a buffer containing 10 mM EDTA, 50 mM Tris pH 8.0, 0.5% lauroyl
sarkosinate, and 0.5 mg/ml protease K (reagents purchased from Sigma Chemical Co.,
St. Louis, MO). The samples were incubated for 1 h at 50 °C, then treated with
RNAse A (100 pg/ml) for 1 h. The samples were heated to 65°C for 5 min and then
analyzed on 1.2% agarose gels containing 0.5 pg/ml ethidium bromide. DNA
laddering was visualized by UV light.
For flow cytometric assay of apoptosis, cells were harvested and labeled with 5
pg/ml propidium iodide in PBS for 15 min at RT. Flow cytometric analysis was
performed using a FACS 420® flow cytometer with fluorescence detected at 620 mn.
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CHAPTER 3
RESULTS

PTK Activity is a Requirement for CD40-Mediated Induction o f IL-1 p Synthesis in
Monocvtes
To determine the nature o f kinase involvement in CD40 signaling in monocytes,
CD40-mediated IL-ip production was evaluated in monocytes pre-treated with inhibitors
o f PTK and PKC activity. As stated above, both PTK activity and the activity o f the PKC
family o f serine/threonine kinases has been demonstrated through CD40 signaling in B
cells. Monocytes were treated either with herbimycin A, a potent, broad PTK inhibitor,
or H-7, an inhibitor o f PKC, prior to anti-CD40 stimulation. The inhibitors were used at
concentrations based on previous reports, as well as experimentally, in that caution was
exercised to ensure that the concentrations used did not affect cell viability and total
protein synthesis. Pre-treatment o f monocytes for 18 h with 0.2 fiM and 1.0 pM
herbimycin A, but not at any o f the concentrations o f H-7 tested, abrogated anti-CD40
stimulation o f IL-1 P synthesis (Figure 3A). Interestingly, IL-ip synthesis was noted to be
moderately increased in anti-CD40 stimulated cells treated with H-7. Neither herbimycin
A or H-7 treatment alone induced IL-ip synthesis (data not shown). These results
indicate a requirement for PTK activity, but not PKC activity, in CD40 signaling o f IL-1 P
synthesis in monocytes.
We hypothesized that, since protein tyrosine phosphorylation does play a critical
role in CD40-mediated monocyte activation, then inhibition o f phosphotyrosine
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Figure 3. Requirement for PTK Activity in CD40-Induced IL -ip Synthesis. A, monocytes
were preincubated for 18 h with various doses o f herbimycin A or H-7, and stimulated
with anti-CD40 for 4 h. Cell lysates were immunoprecipitated for EL-ip and analyzed by
SDS-PAGE. Lane 1, unstimulated; lane 2, anti-CD40 alone; lanes 3-5, anti-CD40 + 0.02
pM, 0.2 pM, and 1.0 pM herbimycin A, respectively; lanes 6-8, anti-CD40 + 2 pM, 4
pM, and 8 pM H-7, respectively. B, monocytes were preincubated for 20 min with
various doses o f Na3V 0 4, and then stimulated with anti-CD40. Cell lysates were
immunoprecipitated for EL-ip and analyzed by SDS-PAGE. Lane 1, unstimulated; lane 2,
anti-CD40 alone; lanes 3-5, anti-CD40 + 10 pM, 50 pM, and 100 pM Na3V 0 4,
respectively; lane 6, 50 pM Na3V04 alone. Each panel represents the results o f one o f
two separate experiments performed with similar results.
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phosphatase (PTP) activity should enhance CD40-mediated IL-ip production due to
maintenance o f the phosphorylated state o f key proteins. To test this hypothesis,
monocytes were pretreated with various doses o f the broad PTP inhibitor Na3V 0 4 for 20
min prior to anti-CD40 stimulation for 4 h. A dose-dependent enhancement o f IL-1 (3
synthesis was noted with increasing concentrations o f Na3V 0 4 compared to untreated
monocytes stimulated with anti-CD40 (Figure 3B).

CD40 Signaling Induces the Rapid Activation o f NF-kB in Monocvtes. an Event
Influenced bv CD40-Induced PTK Activity
NF-kB is involved in the transcription o f the genes for pro-inflammatory
cytokines, including IL -ip. Since CD40-mediated IL-ip synthesis requires PTK activity
(Figure 3), we hypothesized that CD40-induced PTK activity may also be required for the
activation o f NF-kB. Therefore, the effects o f PTK inhibitors on TmA-induced NF-kB
activation were examined. THP-1 monocytic cells were treated for various time intervals
with TmA (with TmRserving as a control), and nuclear localization o f NF-kB was
evaluated by EMSA as described in materials and methods. NF-kB was rapidly activated
(at the 15min time interval) in THP-1 cells stimulated with 5 pg/ml TmA, and was
maximal at ~ 2 h, after which levels began to wane slowly as noted at the 3 h and 4 h
activation periods (Figure 4). NF-kB activation was not observed in THP-1 cells treated
with TmRfor 2h. Based on the observation that CD40-dependent IL-ip synthesis in
monocytes was abrogated by herbimycin A treatment (above data), we hypothesized that
these effects on IL-ip may be at least partially dependent upon the activation state o f NF-
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Figure 4. Kinetics o f CD40-Mediated NF-kB Activation in THP-1 Monocytic Cells.
THP-1 cells were stimulated with 5 jig/ml TmRor TmAfor various time intervals. Cells
were then lysed and nuclear proteins extracted, and an EMS A was performed for NF- kB
activation. Band densities were determined by scanning densitometry. Lane 1,
unstimulated; lane 2 ,2 h TmRstimulation; lanes 3-8, 15 min, 30 min, 1 h, 2 h, 3 h, and 4
h TmA stimulation, respectively; lane 9, cold competition assay o f 2h TmA stimulation.
Data represents one o f two separate experiments that produced similar results.
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kB.

To evaluate the effects o f PTK inhibitors on NF-kB activation in monocytes, THP-1

monocytic cells were treated with pre-determined doses o f herbimycin A, genistein (also
a broad PTK inhibitor), or H-7 for 18 h and then stimulated with TmA. A reduction in
NF- kB activation was observed in TmA-stimulated cells pre-treated with herbimycin A or
genistein compared to untreated cells or cells pre-treated with H-7 in which, as was noted
above for EL-ip synthesis, NF- kB activation was slightly increased (Figure 5).
The effect o f inhibiting PTP activity was also examined in order to further
evaluate the importance o f the PTK pathway in CD40-mediated NF-kB activation. We
hypothesized that because the inhibition of PTP activity augmented CD40-mediated ELip synthesis, then CD40-mediated NF- kB activation would also be enhanced in cells
treated with a PTP inhibitor if protein tyrosine phosphorylation does play a critical role
in CD40-mediated monocyte activation due to maintenance of the phosphorylated state
o f key proteins. To test this hypothesis, THP-1 cells were pretreated with Na3V 0 4 for 20
min prior to 2h TmA stimulation. Enhancement NF-kB activation was noted in THP-1
cells treated with 50 pM and 100 pM concentrations of Na3V 0 4 compared to untreated
cells (Figure 6).

CD40 Signaling Induces the Tyrosine Phosphorylation o f Monocvte Cellular Proteins, an
Event Downregulated by IL-4 and IL-10
Because o f the requirement for PTK activity in CD40-mediated IL-ip synthesis,
the effect o f CD40 stimulation on overall levels o f tyrosine phosphorylation in monocytes
was examined by western blot analysis o f total protein using an anti-phosphotyrosine
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Figure 5. PTK Inhibitors Decrease CD40-Dependent NF-kB Activation in THP-1 Cells.
THP-1 cells were pre-incubated for 18 h with or without herbimycin A, genistein, or H-7,
and then stimulated with TmA for 2 h. Cells were lysed and nuclear proteins were
extracted, and an EMSA was performed for NF- kB activation. Band densities were
determined by scanning densitometry. Lane 1, TmR; lane 2, TmAalone; lane 3, TmA + 0.2
pM herbimycin A; lane 4, TmA + 0.4 pM genistein; lane 5, TmA+ 4 pM H-7. Data
represents one o f two separate experiments that produced similar results.
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Figure 6. Na3V 0 4 Enhances CD40-Dependent NF- kB Activation in THP-1 Cells. THP-1
cells were pre-incubated for 20 min with or without various doses o f Na3V 0 4. Cells were
then stimulated with TmAfor 2 h, followed by lysis o f cells, extraction o f nuclear proteins,
and EMSA for NF- kB activation. Band densities were determined by scanning
densitometry. Lane 1, TmR; lane 2, Tnt^ alone; lanes 3-5, TmA + 10 pM, 50 pM, and 100
pM Na3V 0 4, respectively; lane 6, 100 pM N a3V 0 4 alone. Data represents one o f two
separate experiments that produced similar results.
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mAb. Enhancement o f overall levels of tyrosine phosphorylation of cellular proteins
was apparent in. monocytes treated with either anti-CD40 (Figure 7, Part A, lane 2), or
TmA, representing the natural ligand (Figure 7, Part A, lane 5). The enhanced
phosphorylation was particularly evident on a dominant protein of ~ 68-kDa (indicated
by arrows). Analysis o f CD40-mediated tyrosine phosphorylation was performed at
various time intervals ranging from 10 min to 1 h, and the protein described above
remained the major tyrosine phosphorylated protein at all time points (data not shown).
It has been previously demonstrated that at 6 h post activation of T cells, the time point
at which TmA are prepared, CD40L dominates the monocyte/macrophage-activating
capacity of these cells (Wagner and others 1994; Stout and others 1996; Suttles and
others 1996). Importantly, the ability of Tnf*1 to enhance tyrosine phosphorylation was
blocked by the addition o f a neutralizing anti-CD40L mAb (Figure 7, Part A, lane 6),
again implicating the CD40-CD40L interaction as the primary receptor-ligand pair
involved in T cell stimulation o f monocytes. Since we demonstrated that PTK activity is
required for CD40-dependent signaling of EL-10 synthesis, we investigated whether IL4 and IL-10, cytokines that downregulate LPS-mediated monocyte activation, influence
anti-CD40-induced tyrosine phosphorylation. Monocytes were preincubated for 18 h in
the presence or absence o f IL-4 and/or IL-10 and then stimulated with anti-CD40, and
tyrosine phosphorylation o f cellular proteins was evaluated by western blot. Pre
treatment o f monocytes for 18 h with either EL-4 and/or EL-10 reduced anti-CD40
induced tyrosine phosphorylation of cellular proteins to near basal levels (Figure 7, Part
B). In a separate set o f experiments performed as controls, we observed that
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Figure 7. CD40-Induced Tyrosine Phosphorylation o f Monocyte Cellular Proteins, and
Downregulation by IL-4 and IL-10. A, monocytes were stimulated with 5 pg/ml antiCD40, an IgM isotype control, TmR, TmA, or TmA+ anti-CD40L for 30 min. Cell lysates
were harvested, proteins separated by SDS-PAGE, and a western blot performed for total
tyrosine phosphorylation. Lane 1, unstimulated; lane 2, anti-CD40; lane 3, IgM isotype
control; lane 4, TmR; lane 5, TmA; lane 6, TmA+ anti-CD40L. B, monocytes were
preincubated for 18 h at with 10 ng/ml IL-4 or IL-10, or 5 ng/ml each IL-4 and IL-10, and
then stimulated for 30 min with anti-CD40. Cell lysates were harvested and proteins
analyzed by western blot for total tyrosine phosphorylation. Lane 1, unstimulated; lane 2,
2.5 gg/ml anti-CD40; lane 3, 5 pg/ml anti-CD40; lane 4, 5 pg/ml anti-CD40 + 10 ng/ml
IL-4; lane 5, 5 pg/ml anti-CD40 +10 ng/ml IL-10; lane 6, 5 pg/ml anti-CD40 + 5 ng/ml
each IL-4 and IL-10. Each panel represents one o f three separate experiments performed
that produced similar results.
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herbimycin A, but not H-7 or calphostin C (also a PKC inhibitor), abrogated CD40induced tyrosine phosphorylation o f monocyte cellular proteins (data not shown).

IL-4 and IL-10 Downregulate CD40-Mediated IL-1 ft Synthesis in a Dose-Dependent
Manner, and Svnergize in this Effect
To evaluate the potential modulatory effects o f IL-4 and EL-10 on CD40-mediated
inflammatory cytokine production, monocytes were incubated in the presence or absence
o f various doses o f EL-4 or IL-10 for 18 h and then stimulated with anti-CD40 or TmA.
Compared to untreated monocytes stimulated with anti-CD40, a potent, dose-dependent
downregulation in EL-ip synthesis was observed for cells pretreated with IL-4 (Figure 8,
Part A) or IL-10 (Figure 8, Part B). Also, EL-4 and IL-10 synergize in this effect, as
shown by the complete abrogation o f IL-1 P synthesis with use o f these cytokines together
at either 5 ng/ml or 2.5 ng/ml each, compared to the reduction o f EL-ip when used
individually at 10 ng/ml to pre-treat TmA-stimulated cells (Figure 8, Part C).
Additionally, we have observed that monocyte morphology, degree o f adherence to tissue
culture plates, and ability to carry out de novo protein synthesis are generally unaffected
after the time period o f incubation with IL-4 and/or IL-10, even at the highest
concentrations used, indicating that the downregulatory effects observed on EL-ip are not
due to decreased cell viability (data not shown).
We considered the possibility that the downregulatory effects o f IL-4 and EL-10 on
CD40-mediated IL -ip synthesis were due to a decrease in CD40 cell surface density,
which could prevent anti-CD40 crosslinking and subsequent signal transduction. To
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Figure 8. Effects o f EL-4 and IL-10 on CD40-Mediated EL-ip Induction in Monocytes.
(A) and (B) Monocytes were preincubated for 18 h with, various doses o f IL-4 (A) or EL
IO (B), and then stimulated with anti-CD40. Cell lysates were immunoprecipitated for ELip and analyzed by SDS-PAGE. Lane 1, unstim; lane 2, anti-CD40 alone; lanes 3-7, antiCD40 + 2.5 ng/ml, 5 ng/ml, 10 ng/ml, 50 ng/ml, and 100 ng/ml o f cytokine, respectively.
(C) Monocytes were preincubated with IL-4, EL-10, or IL-4 + IL-10, and then stimulated
with TmAfor 4 h. Lane 1, TmA alone; lane 2, TmA+ 10 ng/ml EL-4; lane 3, TmA+ 10
ng/ml EL-10; lane 4, TmA+ 5 ng/ml each EL-4 and IL-10; lane 5, TmA + 2.5 ng/ml each EL4 and EL-10. Data in each panel represents one o f three separate experiments performed
that produced similar results.
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examine the effects o f EL-4 and DL-10 on CD40 cell surface expression, monocytes were
preincubated with or without 10 ng/ml IL-4 or IL-10, or 5 ng/ml IL-4 + IL-10, for 18 h
and analyzed for the level o f CD40 surface expression by flow cytometry (Figure 9, Part
A). CD40 labeling o f IL-4 treated cells (mean fluorescence intensity, MFI, 58.3) showed
a 20% reduction in CD40 expression as compared to untreated cells (MFI, 72.8). A 37%
reduction in CD40 expression was observed on monocytes treated with IL-10 (MFI, 45.6)
and a 40% reduction in CD40 expression was observed when monocytes were treated
with both cytokines (MFI, 43.7). Although IL-4 and IL-10 treatment reduced CD40
surface expression by as much as 40%, the level o f CD40 expression remaining was
nearly 3-fold above background (MFI, 15). To confirm that the downregulatory effects o f
IL-4 and IL-10 occur primarily at the level o f the CD40 signaling pathway, monocytes
were either treated with IL-4 and/or EL-10 during an 18 h pre-incubation period, or only
upon the addition o f anti-CD40 (when normal levels o f surface CD40 are present), and
downregulation o f IL-1 (3 synthesis was examined. Both IL-4 and IL-10 downregulated
IL-1 P synthesis during co-incubation with anti-CD40 compared to untreated cells,
although this reduction was less dramatic than observed with IL-4 and IL-10 pre
treatment (Figure 9, Part B). The effect o f the addition o f the cytokines only during the
period o f anti-CD40 stimulation was particularly evident in monocytes coincubated with
IL-4 + IL-10, where the reduction in EL-ip synthesis was >50% in repeated experiments.

IL-4. but not IL-10. Blocks CD40-Mediated Rescue o f Monocytes from Apoptosis
We next examined the effects o f IL-4 and IL-10 on CD40-mediated rescue o f monocytes
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Figure 9. IL-4 and EL-10 Effects on CD40 Surface Expression and IL-lp Synthesis when
Added only during Monocyte Stimulation. A, monocytes were preincubated for 18 h with
10 ng/ml IL-4 (top panel), 10 ng/ml IL-10 (middle panel), or 5 ng/ml each IL-4 and IL-10
(bottom panel). Cells were harvested, stained for surface CD40, and analyzed by flow
cytometric analysis. B, monocytes were preincubated for 18 h with or without 10 ng/ml
IL-4 or EL-10, or 5 ng/ml IL-4 + IL-10. Cells were then stimulated for 4 h with antiCD40 in the presence o f the same concentrations o f IL-4 and/or IL-10 added additionally
to pretreated monocytes, or added to previously untreated cells. Cell lysates were
immunoprecipitated for IL-ip and analyzed by SDS-PAGE. Lane 1, anti-CD40 alone;
lanes 2-4, anti-CD40 + IL-4, IL-10, and IL-4/IL-10 preincubation, respectively; lanes 5-7,
EL-4, EL-10, and EL-4/IL-10 treatment, respectively, only during anti-CD40 stimulation.
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from apoptosis induced by serum deprivation. We reasoned that since a previous study
from our laboratory demonstrated that CD40-mediated rescue o f monocytes from
apoptosis was dependent upon PTK activity (Suttles and others 1996), EL-4 and/or IL-10
may block the rescue event. Monocytes were incubated for 72 h in R-0 medium in the
presence or absence o f TmRor TmA, with or without 10 ng/ml IL-4 and/or IL-10. Cells
were then harvested and analyzed for degree o f apoptotic cell death by agarose gel
electrophoresis o f fragmented DNA, or by flow cytometric analysis o f propidium iodide
uptake. Apoptosis by agarose gel electrophoresis is evidenced by characteristic DNA
“laddering” o f multiples o f —200 bp (oligonucleosome-sized) fragments, and is shown
flow cytometrically by increased uptake o f propidium iodide and decreased cell size.
Interestingly, EL-4, but not IL-10, blocked CD40-mediated rescue of monocytes from
apoptosis (Figures 10 and 11). Additionally, the effect o f IL-4 and IL-10 coincubation on
rescue from apoptosis was unchanged from that o f treatment with IL-4 alone (Figure 11).

CD40-Med?ated IL-ip Synthesis is Dependent Upon Erk MAPK Activity
To determine which specific kinases are involved in signal transduction in the
CD40 signaling pathway in monocytes, a panel o f kinases whose activation states are
dependent upon the phosphorylation o f tyrosine residues and which are possible
candidates for CD40-mediated signaling were examined. O f the panel o f kinases
evaluated, it was determined that CD40 signaling is critically dependent upon the
activation o f the Erkl/Erk2 MAPKs. This is in contrast to previous observations in B
cells in which JNK, but not Erkl/Erk2, mediates signaling through CD40 that is
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Figure 10. IL-4 and EL-10 Effects on CD40-Mediated Rescue o f Monocytes from
Apoptosis as Examined by Agarose Gel Electrophoresis. Monocytes were incubated in
R-0 in the presence o f TmR, TmA, TmA+ 10 ng/ml EL-4, or TmA+ 10 ng/ml EL-10 for 72
h. Cells were harvested and analyzed for degree of apoptosis by separation o f DNA
fragments by agarose gel electrophoresis. Lane 1, unstim; lane 2, TmR; lane 3, TmA; lane
4, TmA+ IL-4; lane 5, TmA+ IL-10. Data represents one o f three separate experiments
performed that produced similar results.
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Figure 11. EL-4 and IL-10 Effects on CD40-Mediated Rescue o f Monocytes from
Apoptosis as Examined by Flow Cytometric Analysis. Monocytes were incubated in R-0
in the presence o f TmR, TmA, TmA + 10 ng/ml IL-4, or TmA+ 10 ng/ml IL-10 for 72 h.
Cells were harvested and analyzed for degree o f apoptosis by flow cytometry, with
forward scatter (cell size) represented on the X-axis, and fluorescence (propidium iodide
uptake) represented on the Y-axis. Results each represent one o f two separate
experiments performed with similar results.

R eprod u ced with permission o f the copyright owner. Further reproduction prohibited without permission.

37
dependent upon MAPK activity (Sakata and others 1995; Sutherland and others 1996).
Although they belong to the family o f MAPK’s, Erkl/Erk2 and JNK are activated by
distinct mechanisms (Figure 1). Treatment o f monocytes with TmA, but not TmR, resulted
in the rapid, dramatic activation o f both Erkl and Erk2 (Figure 12), as observed by
western blot using an anti-active Erkl/Erk2 MAPK pAb that specifically recognizes the
dually phosphorylated (Thr and Tyr in the catalytic core) forms o f Erkl and Erk2.
Importantly, pre-treatment o f TmAwith anti-CD40L mAb, but not with an isotypematched control mAb, greatly reduced CD40-dependent Erkl/Erk2 activation,
demonstrating again that CD40L is the primary monocyte-activating component o f TmA.
To confirm that CD40-mediated EL-ip induction is dependent upon Erkl/Erk2
activity, monocytes were pre-treated with the highly-specific MEK1/MEK2 inhibitor
PD98059 prior to TmA stimulation o f monocyte IL-ip synthesis. Because Erkl and Erk2
are specifically activated by, and are the only known substrates for, MEK1 and MEK2,
the downregulation o f IL-ip production with the use o f this inhibitor would confirm the
requirement for Erkl and Erk2 in CD40 signal transduction. To ensure that the
MEK1/MEK2 inhibitor was used at concentrations that effectively diminish Erkl/Erk2
activation in our system, monocytes were pre-treated with this reagent at dose ranges
recommended by the manufacturer and then stimulated with TmA, and western blots were
performed to evaluate effects on Erkl/Erk2 activation. Use o f the inhibitor at the
recommended doses effectively inhibited Erkl/Erk2 activation (Figure 13, Part A).
Importantly, PD98059 had no adverse effects on cell viability at the concentrations used,
even during prolonged periods of treatment, as confirmed by examining total de novo
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Figure 12. CD40-Dependent Signaling o f Erkl/Erk2 MAPK Activation in Monocytes.
Monocytes were treated for 20 min with TmR, or with TmA in the presence or absence of
anti-CD40L or isotype control antibodies. Cell lysates were harvested, proteins were
separated by SDS-PAGE, and a western blot performed for Erkl/Erk2 activation. The
membrane was then stripped and reprobed with anti-(3-actin. Lane 1, unstim.; lane 2,
TmR; lane 3, TmA alone; lane 4, TmA+■anti-CD40L; lane 5, TmA+ isotype control.
Results represent one of four separate experiments performed that produced similar
results.
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Figure 13. Requirement for Erkl/Erk2 MAPK Activity for CD40 Signaling o f IL-lp
Synthesis in Monocytes. (A) Monocytes were pre-incubated for 1 h in the presence or
absence o f the MEK1/MEK2 inhibitor PD98059, and then stimulated with TmA for 20
min. Erkl/Erk2 activation was then evaluated by western blot as described above. Lane
1, unstim; lane 2, TmAalone; lane 3, TmA+ 30 pM PD98059. (B) Monocytes were preincubated for 1 h in the presence or absence o f various doses o f PD98059, and then
stimulated with TmA for 4 h during metabolic protein labeling. Cell lysates were
harvested and immunoprecipitated for IL-ip as described in materials and methods. Lane
1, unstim.; lane 2, TmA; lane 3, TmA + 1 pM PD98059; lane 4, TmA + 5 pM PD98059;
lane 5, TmA+ 30 pM PD98059. Each panel represents one of three separate experiments
performed that produced similar results.
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protein synthesis after metabolic labeling o f cells with radioactive amino acids. Also,
monocyte morphology and degree of adherence to tissue culture plates were unaffected by
the inhibitor (data not shown). Pre-treatment o f monocytes with the MEK1/MEK2
inhibitor effectively blocked CD40-mediated IL-ip induction, and this inhibition
occurred in a dose-dependent manner (Figure 13, Part B), confirming the requirement for
Erkl/Erk2 activity.

IL-4 and IL-10 Downregulate CD40-Mediated Erk MAPK Activation Individually and
Svnergize in this Effect When Used Concurrently
Because it was confirmed from experiments described above that Erkl/Erk2
MAPK activity is critical to CD40-dependent IL-ip synthesis, we hypothesized that the
downregulatory effects o f EL-4 and IL-10 on CD40 signaling may occur through the
inhibition o f Erkl/Erk2 phosphorylation. Additionally, we hypothesized that the
synergistic effects o f IL-4 and IL-10 observed on IL-ip production may occur as a direct
result o f synergy in the inhibition o f Erkl/Erk2 activation. Monocytes were pre-treated
with IL-4 or IL-10 alone, or in combination at reduced doses, followed by TmA
stimulation. IL-4 and IL-10 each reduced Erkl/Erk2 activation when used individually,
and the inhibition o f Erkl/Erk2 activation was dramatically enhanced when the cytokines
were used in combination (Figure 14).

Differential Activation o f Members of the Jak-STAT Family o f Signaling Proteins bv IL4 and IL-10 in the Downregulation of CD40 Signaling
IL-4 and IL-10, like other cytokines, exert their effects by utilizing members o f the
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Figure 14. EL-4 and EL-10 Effects on CD40-Mediated Erkl/Erk2 Activation. Monocytes
were pre-incubated for 18 h in the presence or absence o f EL-4 and/or IL-10, followed by
stimulation with TmAfor 20 min. Cell lysates were harvested and analyzed by western
blot for Erkl/Erk2 activation. The membrane was then stripped and reprobed with anti-Pactin. Lane 1, TmR; lane 2, TmA; lane 3, TmA+ 10 ng/ml IL-4; lane 4, TmA + 10 ng/ml IL10; lane 5, TmA+ 5 ng/ml each IL-4 and IL-10. Results represent one o f three separate
experiments performed that produced similar results.
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Jak-STAT family o f signaling molecules (Figure 2). The fact that both IL-4 and EL-10
downregulate IL-ip production through CD40 signaling indicates that these cytokines
induce Jak-STAT signaling cascades that mediate similar downstream functions.
However, the data described above also suggest that the downstream events mediated by
these cytokines are not identical. Rather, as is the case with IL-1(3 synthesis and MAPK
activation, the function o f one cytokine augments the function o f the other in
downregulatory activity. In addition, the fact that EL-4, but not EL-10, blocks CD40mediated rescue o f monocytes from apoptosis further supports the hypothesis that these
cytokines affect the monocyte CD40 signaling pathway in a distinct manner. A likely
mechanism for the disparate actions o f IL-4 and EL-10 on CD40 signaling is the
utilization o f different Jak kinases/STAT transcription factors characteristic o f these
cytokines (described above). In preliminary studies, we evaluated the possible role o f
STATS activation by IL-10 in the downregulatory action o f this cytokine on CD40dependent signaling. This was made possible by the commercial availability o f an Ab
that is specific for the activated form o f STAT3. As stated above, IL-10-mediated
responses are believed to involve the activation o f STAT1 and STAT3 by Jakl and Tyk2.
However, whether STAT3 activation is maintained for the duration o f the incubation
period with which we observe maximal IL-10 downregulatory actions (18 h) through
CD40 signaling in monocytes is unknown. Also, whether the synergistic effects o f IL-4
in combination with IL-10 described above occur as a result o f an augmentation ofEL-10mediated STAT3 activation by IL-4 remains to be elucidated. Therefore, the effects o f
the pre-incubation of monocytes with IL-10 and EL-4 prior to stimulation through CD40
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on STAT3 activation was evaluated (Figure 15). Pre-treatment o f monocytes with IL-10,
but not IL-4, resulted in a strong activation of STAT3. Also, STAT3 activation was
maintained in monocytes treated with a combination o f IL-10 and EL-4, where each
cytokine was used at one-half the dose o f that when used individually. Additionally, a
slight activation o f STAT3 was observed in monocytes treated with TmA alone.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

44

-<ST A T 3

Figure 15. IL-4 and IL-10 Effects on CD40-Mediated STAT3 Activation in Monocytes.
Monocytes were pre-incubated for 18 h in the presence or absence o f EL-4 and/or IL-10,
followed by stimulation with TmA for 20 min. Cell lysates were harvested and analyzed
by western blot for STAT3 activation. The membrane was then stripped and reprobed
with anti-P-actin. Lane 1, TmR; lane 2, TmA; lane 3, TmA+ 1 0 ng/ml EL-4; lane 4, TmA+
10 ng/ml IL-10; lane 5, TmA+ 5 ng/ml each IL-4 and IL-10.
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CHAPTER 4
DISCUSSION

The CD40L-CD40 interaction is critical in early cell contact-dependent signaling
of monocyte/macrophage activation by Th cells in normal cell-mediated immune
responses (Alderson and others 1993; Wagner and others 1994; Tian and others 1995;
Stout and others 1996; Stout and Suttles 1996; Suttles and others 1996). During
episodes o f autoimmune inflammation, self-antigen-responsive Th cells recruited to an
inflammatory site have the potential, once activated, to in turn activate resting
monocytes solely through CD40 ligation, and thus independently of direct antigen
presentation by the target monocyte. CD40 engagement on resting monocytes in the
synovia of an individual with rheumatoid arthritis would induce IL-ip synthesis
(Alderson and others 1993; Wagner and others 1994; Stout and others 1996), leading to
sustainment or exacerbation o f the inflammatory response, eventually resulting in
localized tissue destruction. The presence o f IL-lp would also likely induce the
maintenance o f homing receptor and adhesion molecule expression in affected synovial
tissues, allowing further infiltration of leukocytes to these sites.
Experiments described in this dissertation were performed to determine the
nature of the CD40 signaling pathway in monocytes that results in activation of IL-ip
synthesis and rescue from apoptosis, and the means by which these CD40-mediated
events are modified by IL-4 and IL-10, cytokines with anti-inflammatory function (see
also Poe and others 1997). Treatment o f monocytes with either anti-CD40 or TmA
45

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

46
resulted in the activation o f NF-kB, an increase in overall tyrosine phosphorylation o f
cellular proteins, and in the striking activation of the Erkl and Erk2 MAPK’s. The
increase in tyrosine phosphorylation is functionally relevant as evidenced by the
observations that 1) inhibitors o f cellular PTK activity blocked CD40 stimulation o f ILip synthesis and reduced NF-kB activation and 2) treatment with N%V04, an inhibitor
of PTP activity, enhanced CD40-mediated stimulation o f IL-P synthesis and NF-kB
activation (Figures 3-6). Inhibition of PKC activity did not reduce these signaling
events. Also, it was observed that the activation of the Erk MAPK’s is critical to CD40
signaling in that the specific inhibition o f MEK1 and MEK2, kinases that directly
activate Erkl and Erk2, abrogated IL-ip synthesis induced by Tm*" stimulation (Figure
13). Furthermore, the induction o f PTK activity and o f Erkl/Erk2 MAPK activity by
TmA stimulation was confirmed to be dependent upon CD40L, in that pre-treatment o f
TmA with anti-CD40L neutralizing antibodies reduced both PTK (Figure 7) and
Erkl/Erk2 (Figure 12) activation.
The critical dependence of CD40-mediated IL-lp synthesis on Erkl/Erk2
activity is an important observation since in previous reports it was demonstrated that
CD40 signaling in B cells does not induce Erk activation. Rather, CD40 signaling in B
cells has been shown to activate JNK, a distinct member o f the MAPK family that is
activated independently o f MEK1 and MEK2, the kinases that activate Erkl and Erk2
(Figure 1). This suggests that CD40 signaling events specific to monocytes, such as the
induction of pro-inflammatory cytokine synthesis, occur through the utilization of
signaling mechanisms that are distinct from those utilized by the CD40 signaling

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

47
pathway in other cell types. Although Erkl/Erk2 activation by MEK1/MEK2 in most
signaling pathways studied (that utilize MAPK’s) has been shown to be dependent upon
the Ras-raf signaling cascade, we have observed that CD40 signaling in monocytes does
not induce Ras activation (data not shown). This observation is in contrast to LPS
signaling in monocytes which has been shown to induce raf activation, directly
implicating Ras involvement (Reinmann and others 1994). Furthermore, our data
suggests that the CD40 signaling pathway in monocytes differs significantly from that
o f LPS in that LPS-mediated signaling of IL-ip and TNFa production in monocytes has
been shown to be abrogated by inhibitors of PKC activity (Shapira and others 1994),
indicating a requirement for PKC activity in LPS-mediated inflammatory cytokine
induction. Despite the apparent differences between the signaling pathways employed
by LPS and CD40, in both cases IL-4 and IL-10 are effective as inhibitors of
inflammatory cytokine production induced by these pathways. The inhibitory effects o f
these cytokines are unlikely to be at the level CD40 surface expression in that, although
IL-4 and IL-10 reduced the level o f monocyte CD40 expression, the level of CD40
expression remained nearly 3-fold above background and addition o f the cytokines at
the onset of a 4 h anti-CD40 stimulation of monocytes reduced IL -lp production
(Figure 9). Also, the fact that EL-4 and IL-10 synergize in the downregulation of
Erkl/Erk2 MAPK activation (Figure 14) and IL -ip synthesis (Figure 13), but only
decrease CD40 surface expression slightly more than that of IL-10 treatment alone,
suggests that this decrease in expression is unlikely to be a major factor in the observed
effects o f IL-4 and IL-10 on CD40 responsiveness. Finally, IL-10 does not prevent the
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rescue of monocytes from apoptosis by Tm* stimulation (Figures 10, 11), indicating
that CD40 expression levels remain adequate for signal transduction to occur in IL-10treated cells.
Two previous studies that evaluated the mechanisms o f IL-4 and EL-10
downregulation o f LPS-induced pro-inflammatory cytokine synthesis suggested that EL4 and EL-10 act by altering LPS-induced cytokine message stability (Wang and others
1995; Takeshita and others 1996). However, although EL-4 and EL-10 were found to
differentially affect inflammatory cytokine mRNA stability in monocytes or monocytic
cell lines stimulated with LPS, the results of these two studies are somewhat
conflicting. In one study EL-4, but not EL-10, was shown to decrease inflammatory
cytokine message stability, including the pro-inflammatory cytokine EL-6, in LPSstimulated monocytes (Wang and others 1995). In a separate study, it was observed
that EL-6 mRNA degradation is enhanced by EL-10, but not EL-4, in LPS-stimulated
monocytic cell lines (Takeshita and others 1996). Our data suggest, however, that IL-4
and IL-10 may act at the same point, as well as at distinct points, in the CD40 signaling
pathway. This is shown first by the fact that both cytokines similarly reduce CD40associated PTK activity (Figure 7B) and levels o f EL-1 P synthesis (Figure 8A and B),
suggesting overlapping effects of these cytokines. However, our data also suggest that
EL-4 and IL-10 have divergent effects on monocyte CD40 signaling in that 1) these
cytokines synergize in the downregulation of Erkl/Erk2 activation (Figure 14) and ELip production (Figure 8C), even when used at low doses, and 2) unlike IL-4, IL-10
does not block CD40-mediated rescue of monocytes from apoptosis (Figures 10, 11).
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We reported previously that neutralizing antibodies against IL-1 and TNF-a fail to
block CD40-mediated rescue of monocytes from apoptosis (Suttles and others 1996),
suggesting a lack o f dependence on any autocrine effects of these cytokines in this
process. Our current data further supports this observation by the fact that IL-10
dramatically downregulates CD40-induced EL-ip synthesis, but does not block rescue
from apoptosis.
An additional observation made during our research is that IL-4 and IL-10,
either individually or in combination, have negligible downregulatory effects on CD40mediated NF- kB activation (data not shown). This is an interesting observation since
we have shown here that PTK activity is required for CD40-dependent EL-ip synthesis,
and PTK inhibitors diminish NF-kB activation. There are several possibilities that may
explain this occurrence. First, PTK inhibitors completely abrogated IL-ip synthesis,
but only partially inhibited NF-kB activation. This suggests that other PTK-dependent
transcription factors are involved in EL-ip synthesis, and these proteins may be the
primary targets for the downregulatory actions of IL-4 and EL-10. Second, signaling
events that lead to NF- kB activation, although dependent upon PTK activity, may be
divergent from those that are influenced by IL-4 and IL-10. Third, although NF- kB
may be critical to IL-ip gene transcription, signaling events that lead to NF-kB
activation may lie upstream of the Erkl/Erk2 signaling cascade, the point in the CD40
signaling pathway at which IL-4 and EL-10 exert their downregulatory effects (Figure
16). It has been reported previously that NF-kB activity is required for the prevention
o f factor-induced apoptosis in some cell types (Arsura and others 1996). Therefore,
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the fact that IL-10 does not block CD40-mediated rescue from apoptosis provides
mechanistic support to the observation that IL-10 does not downregulate NF-kB
activation, the maintenance of which may be vital to the rescue event.
The mechanisms through which IL-4 and IL-10 differentially influence CD40
signal transduction in monocytes likely result from the use of distinct Jak kinases and
ST AT transcription factors by these cytokines. While it has been elucidated which
members o f these families of signaling proteins are used by EL-4 and IL-10 when used
individually, it is currently unknown whether treatment of monocytes with IL-4 and EL
IO in combination results in the differential utilization of Jak-STAT proteins. As stated
above, IL-4 signaling involves the activation of STAT6 by Jak3, and EL-10 signaling
involves the activation o f STAT1 and STAT3 by Jakl and/or Tyk2 (Figure 2). Pre
treatment o f monocytes with IL-10 resulted in the strong phosphorylation of STAT3
(Figure 15). To a lesser degree, STAT3 was activated in monocytes treated with TmA
alone (lane 2). It is possible that STAT3 activation by Tm!41may eventually result in the
establishment o f a negative feedback loop that downregulates TmNmediated proinflammatory cytokine synthesis over time, similar to the downregulatory effects
induced by EL-10. Because the time period o f activation by Tm* alone (20 min) in this
analysis was much shorter than that o f the time period of EL-10 treatment (18 h), high
level STAT3 activation may not have occurred. As expected, IL-4 did not induce
STAT3 activation. However, the slight activation o f STAT3 that occurred with TmA
stimulation alone was reduced in the IL-4 treated cells (lane 3). The reason for this is
most likely not that EL-4 directly downregulates STAT3 activation, but that STAT3
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activation does not occur with TmA stimulation o f IL-4-treated cells because o f the
downregulatory effects of EL-4 on CD40 signaling. This hypothesis is further
strengthened by the observation that STAT3 remained activated in monocytes pre
treated with a combination o f EL-4 and IL-10 (lane 5), in which the reduced level o f
STAT3 activation observed compared to IL-10 treatment alone is probably a result of
EL-10 being used at a reduced concentration. The establishment o f a negative feedback
loop by CD40-mediated STAT3 activation would explain how EL-1 (3 induction by TmA
may, like other known cellular responses, generally diminish over time. However,
because resting monocytes are continually being recruited to the inflamed synovia o f
individuals with RA, where they are subsequently activated by Th cells, the
establishment o f a negative feedback loop in previously activated monocytes would
likely not substantially reduce the overall inflammatory response.
It is also possible that the formation o f unique STAT heterodimers occurs in
monocytes treated with a combination of EL-4 and EL-10 (Figure 2), which could
explain their differential effects on CD40 signaling. To date, however, the existence of
such heterodimers through cytokine signaling has not been determined.
Finally, recent studies have shown that direct cross-talk can occur between the
MAPK and Jak-STAT signaling pathways during signal transduction, suggesting that
signals transduced through one cascade may directly influence those o f the other (David
and others 1995; Winston and Hunter 1995). For example, signal transduction through
the EFN-a/p receptor causes Erk2 and STAT1 to coimmunoprecipitate (David and
others 1995). Such direct interactions between Erk and STAT proteins during CD40
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signaling in monocytes may also occur, and may provide a mechanism through which
IL-4 and IL-10 exert their downregulatory effects on MAPK activity.
The use o f IL-4 and IL-10 as therapeutic agents in the treatment o f autoimmune,
cell-mediated inflammatory responses has been suggested based on the ability of these
cytokines to redirect T cell responses from a Thl to Th2-like phenotype (Mosmann and
Moore 1991; Sher and others 1991; Chatelain and others 1992; Maggi and others 1992;
Sher and others 1992; Mocci and Coffman 1995). Our results suggest that these
cytokines also selectively uncouple signaling pathways o f the T cellmonocyte/macrophage CD40L;CD40 interaction. During an active inflammatory
response, the primary effects of IL-4 and IL-10 are likely to be due to their direct
inhibition o f monocyte/macrophage function. As the results herein show, the influence
o f IL-4 and EL-10 occurred at the level of macrophage cytokine production. The fact
that IL-4 and IL-10 synergize in EL-ip downregulation suggests that these cytokines
could be used simultaneously at much lower doses than when used individually to exert
sufficient anti-inflammatory effects. EL-4 has the additional ability to block CD40mediated rescue of monocytes from apoptosis, and since EL-10 does not antagonize EL-4
in this effect, the use o f EL-4 and EL-10 together would not interfere with the ability of
EL-4 to mediate the loss o f inflammatory monocytes at sites o f chronic, non-septic
inflammation.
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